T cells equipped with TCRs recognize the antigens presented by MHC molecules on the surface of tumor cells, whereas T cells with CARs recognize tumor-specific cell surface antigens that do not need to be restricted by MHC [159]. Here, HLA-C is linked to neoplasm.